Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papilloma Virus Vaccines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04313244
What this trial is testing

Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years

Who this might be right for
Dengue Fever
Takeda 614
Post-approval studies (Phase 4)Active Not RecruitingNCT05557370
What this trial is testing

Immunogenicity of HPV Vaccine in Transplant Recipients.

Who this might be right for
Chronic Kidney DiseasesKidney Transplant
Medical College of Wisconsin 30
Not applicableStudy completedNCT02280642
What this trial is testing

Alternate Dosing Schedules Study for HPV Vaccine (ADS)

Who this might be right for
Cervical CancerGenital Warts
Duke University 331
Not applicableStudy completedNCT03763565
What this trial is testing

Effectiveness of HPV Vaccine in Thai Adult Women

Who this might be right for
Uterine Cervical DysplasiaPapillomavirus Vaccines
Mahidol University 993
Large-scale testing (Phase 3)Study completedNCT03431246
What this trial is testing

Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9

Who this might be right for
Human Papillomavirus Vaccines
Laval University 32
Large-scale testing (Phase 3)Study completedNCT00196924
What this trial is testing

Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 2,067
Not applicableStudy completedNCT03002324
What this trial is testing

Tailoring of Vaccine-Focused Messages: Disease Salience

Who this might be right for
Human Papillomavirus
Emory University 1,320
Large-scale testing (Phase 3)Study completedNCT00637195
What this trial is testing

Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 152
Large-scale testing (Phase 3)Study completedNCT03493542
What this trial is testing

Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)

Who this might be right for
Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ
Merck Sharp & Dohme LLC 766
Testing effectiveness (Phase 2)Study completedNCT00586339
What this trial is testing

Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 150
Not applicableEnded earlyNCT02535845
What this trial is testing

Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial

Who this might be right for
Human Papillomavirus Vaccines
University of Texas Southwestern Medical Center 22
Not applicableUnknownNCT04905030
What this trial is testing

Education, Immigration and HPV Vaccination: an Informational Randomized Trial

Who this might be right for
Cervical CancerVulvar CancerAnus Cancer+5 more
Karolinska Institutet 2,500
Early research (Phase 1)Ended earlyNCT00798265
What this trial is testing

A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults

Who this might be right for
Human Immunodeficiency VirusHuman Papillomavirus- 6, 11, 16, 18Adolescent+1 more
National Cancer Institute (NCI) 26
Early research (Phase 1)Study completedNCT05518201
What this trial is testing

Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old

Who this might be right for
Penile CancerAnal CancerPIN-1+6 more
Shanghai Bovax Biotechnology Co., Ltd. 90
Early research (Phase 1)UnknownNCT06454175
What this trial is testing

A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years

Who this might be right for
HPV InfectionHPV-Related CarcinomaGenital Wart+1 more
Shanghai Bovax Biotechnology Co., Ltd. 72
Not applicableStudy completedNCT04667702
What this trial is testing

HPV Vaccine Hesitancy Among Indiana Youth With Cancer and Blood Diseases

Who this might be right for
Human Papilloma Virus Vaccine Hesitancy
Indiana University 176
Not applicableStudy completedNCT04576962
What this trial is testing

County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana

Who this might be right for
Human Papillomavirus Vaccination
Indiana University 122,152
Testing effectiveness (Phase 2)Active Not RecruitingNCT05108870
What this trial is testing

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Who this might be right for
Human Papilloma VirusHPVHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more
University of Chicago 35
Not applicableUnknownNCT03747770
What this trial is testing

Effectiveness of Single Dose or Two Doses of Bivalent HPV Vaccine in Thailand

Who this might be right for
Healthy
International Vaccine Institute 18,000
Not applicableStudy completedNCT01535794
What this trial is testing

HPV Vaccine Acceptability Among Young Men Who Have Sex With Men

Who this might be right for
HPV Vaccine AttitudesHPV Vaccine Intention
Indiana University 2,000
Next Page